Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial

β(2)-agonist treatment improves skeletal muscle glucose uptake and whole-body glucose homeostasis in rodents, likely via mTORC2-mediated signalling. However, human data on this topic is virtually absent. We here investigate the effects of two-weeks treatment with the β(2)-agonist clenbuterol (40 µg/...

Descripción completa

Detalles Bibliográficos
Autores principales: van Beek, Sten M. M., Bruls, Yvonne M. H., Vanweert, Froukje, Fealy, Ciarán E., Connell, Niels J., Schaart, Gert, Moonen-Kornips, Esther, Jörgensen, Johanna A., Vaz, Frédéric M., Smeets, Ellen T. H. C., Joris, Peter J., Gemmink, Anne, Houtkooper, Riekelt H., Hesselink, Matthijs K. C., Bengtsson, Tore, Havekes, Bas, Schrauwen, Patrick, Hoeks, Joris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835033/
https://www.ncbi.nlm.nih.gov/pubmed/36635304
http://dx.doi.org/10.1038/s41467-023-35798-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835033/
https://www.ncbi.nlm.nih.gov/pubmed/36635304
http://dx.doi.org/10.1038/s41467-023-35798-5

Ejemplares similares